What Is Fuchs’ Dystrophy?

Fuchs’ endothelial corneal dystrophy, usually called Fuchs’ dystrophy, affects the inner layer of the cornea, the clear window at the front of your eye.

This layer contains cells that pump excess fluid out of the cornea to keep it clear. In Fuchs’ dystrophy, these cells gradually decrease in number and function. Fluid can build up, causing swelling and cloudy vision.

The condition usually affects both eyes, although one may be more affected than the other. It often progresses slowly over many years.

What Symptoms Might You Notice?

Early Fuchs’ dystrophy may cause no noticeable symptoms. As it progresses, you may experience:

With more advanced swelling, vision may remain blurred throughout the day. Small blisters on the corneal surface can sometimes cause discomfort or pain.

Does Everyone Need Treatment?

No. Some people have mild Fuchs’ dystrophy that can be monitored without surgery.

During your examination, I look for changes in the cornea’s inner layer and signs of swelling. Measurements of corneal thickness, specialized imaging, and sometimes endothelial cell photographs help assess the condition.

Your symptoms, examination findings, and changes over time guide treatment. The goal is to understand how much Fuchs’ is affecting your vision and when treatment may help.

How Is Fuchs’ Dystrophy Treated?

Treatment depends on the severity of your condition and how it affects your daily life.

Monitoring and symptom relief

For mild disease, regular examinations may be all that is needed. Hypertonic saline drops or ointment, such as sodium chloride 5%, may help reduce swelling and morning blur in some patients. These treatments relieve symptoms but do not replace lost endothelial cells.

Partial-thickness corneal transplantation

When Fuchs’ significantly affects vision, surgery can replace the damaged inner layers of the cornea with healthy donor tissue.

Both approaches preserve most of your own cornea. The choice depends on your eye’s anatomy, previous surgery, and other eye conditions.

Recovery requires prescribed eye drops and follow-up visits. Temporary positioning is needed to help the donor tissue attach, and some patients require an additional air or gas injection. We will discuss the expected benefits, risks, and recovery before surgery.

Alternatives to a Corneal Tissue Transplant

Descemet Stripping Only (DSO)

For carefully selected patients, DSO removes a small central area of diseased tissue so that healthier endothelial cells from the surrounding cornea can move inward.

This approach requires enough healthy cells in the outer cornea. Specialized drops called ROCK inhibitors may support recovery; it is off-label in the US.

Vision may take weeks to months to improve. If the cornea does not clear adequately, a transplant may still be needed.

Cultured Endothelial Cell Injection

This approach uses healthy donor endothelial cells grown in a specialized laboratory. The cells are injected into the front chamber of the eye, with the aim of restoring the cornea’s fluid-pumping function and improving clarity.

Unlike DMEK or DSEK, it does not involve placing a sheet of donor tissue. It may offer an alternative for selected patients with corneal endothelial disease.

Cell therapy is approved in Japan for bullous keratopathy, a condition involving corneal swelling from endothelial failure. In the United States, cultured endothelial cell therapy remains investigational and is being evaluated in several clinical trials.

Suitability depends on your corneal condition and access to an approved treatment or clinical study.

Looking Ahead

Researchers are also exploring gene-targeted treatments for Fuchs’ dystrophy. As these options develop, I can help you understand which treatments are established, which are still being studied, and what may be appropriate for your eyes.

What If I Also Have Cataracts?

Fuchs’ dystrophy and cataracts can both cause blur and glare. Before recommending surgery, I assess how much each condition contributes to your symptoms.

Cataract surgery places additional stress on the cornea’s endothelial cells. Some patients with mild Fuchs’ can have cataract surgery alone, while others benefit from a corneal procedure performed before, after, or together with cataract surgery.

Fuchs’ also influences lens selection. We will discuss how your corneal health may affect visual quality, lens measurements, and the suitability of different lens options.

The plan is tailored to your eyes and your visual goals.

Moving Forward With Confidence

A diagnosis of Fuchs’ dystrophy does not automatically mean you need surgery. Many people can be monitored for years, and effective treatments are available when vision becomes affected.

As a cornea and cataract surgeon, I will help you understand your findings, review your options, and decide on the right timing for treatment.

Bring your questions to your consultation—especially if you notice increasing morning blur, glare, or changes in your daily vision. CLICK HERE for scheduling your consultation.